These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30210045)

  • 21. Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: is there a role for radiation therapy?
    Cosar R; Uzal C; Tokatli F; Denizli B; Saynak M; Turan N; Uzunoglu S; Ozen A; Sezer A; Ibis K; Uregen B; Yurut-Caloglu V; Kocak Z
    Radiat Oncol; 2011 Mar; 6():28. PubMed ID: 21450076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of ECE on the benefits of PMRT for breast cancer patients with positive axillary nodes.
    Geng W; Zhang B; Li D; Liang X; Cao X
    J Radiat Res; 2013 Jul; 54(4):712-8. PubMed ID: 23392824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy.
    Lai SF; Chen YH; Kuo WH; Lien HC; Wang MY; Lu YS; Lo C; Kuo SH; Cheng AL; Huang CS
    Ann Surg Oncol; 2016 Nov; 23(12):3860-3869. PubMed ID: 27436202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy.
    Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y
    Int J Clin Oncol; 2013 Feb; 18(1):54-61. PubMed ID: 22068463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
    Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
    Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
    Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M
    Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes.
    Matsunuma R; Oguchi M; Fujikane T; Matsuura M; Sakai T; Kimura K; Morizono H; Iijima K; Izumori A; Miyagi Y; Nishimura S; Makita M; Gomi N; Horii R; Akiyama F; Iwase T
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):845-52. PubMed ID: 22138460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease : An individual patient data analysis of three clinical trials.
    Abdel-Rahman O
    Strahlenther Onkol; 2019 Apr; 195(4):297-305. PubMed ID: 30069737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.
    Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Jian JJ; Cheng SH; Tsai SY; Leu SY; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):980-8. PubMed ID: 11958892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger.
    Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y
    Breast Cancer; 2014 May; 21(3):292-301. PubMed ID: 22890603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions.
    Wang S; Wen G; Tang Y; Yang Y; Jing H; Wang J; Zhang J; Zhao X; Sun G; Jin J; Song Y; Liu Y; Fang H; Zhang Y; Li Y
    BMC Cancer; 2020 Aug; 20(1):792. PubMed ID: 32838753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
    Tang Y; Zhang YJ; Zhang N; Shi M; Wen G; Cheng J; Wang HM; Liu M; Wang XH; Guo QS; Wu HF; Ma CY; Jin J; Liu YP; Song YW; Fang H; Ren H; Wang SL; Li YX
    Cancer; 2020 Aug; 126 Suppl 16():3857-3866. PubMed ID: 32710662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.
    Recht A; Comen EA; Fine RE; Fleming GF; Hardenbergh PH; Ho AY; Hudis CA; Hwang ES; Kirshner JJ; Morrow M; Salerno KE; Sledge GW; Solin LJ; Spears PA; Whelan TJ; Somerfield MR; Edge SB
    Pract Radiat Oncol; 2016; 6(6):e219-e234. PubMed ID: 27659727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of extracapsular extension of axillary lymph node metastases in breast cancer.
    Ilknur GB; Hilmi A; Tülay C; Oguz C; Selma S; Serdar S; Uğur Y; Pinar B; Omer H; Münir K;
    Tumori; 2004; 90(1):107-11. PubMed ID: 15143982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy.
    Macdonald SM; Abi-Raad RF; Alm El-Din MA; Niemierko A; Kobayashi W; McGrath JJ; Goldberg SI; Powell S; Smith B; Taghian AG
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1297-303. PubMed ID: 19327896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
    Willner J; Kiricuta IC; Kölbl O
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
    Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmastectomy radiation and survival in patients with breast cancer.
    Yadav BS; Sharma SC; Singh R; Singh G; Kumar V
    J Cancer Res Ther; 2007; 3(4):218-24. PubMed ID: 18270397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.